Markus Puhlmann compensation by year
Perspective Therapeutics Summary Compensation Table · all 3 fiscal years held| Component | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Salary | $420,846 | $489,723 | $516,700 |
| Bonus | $3,333 | $0 | $0 |
| Stock awards | $0 | $0 | $0 |
| Option awards | $266,953 | $1,327,100 | $330,683 |
| Non-equity incentive | $184,000 | $198,720 | $206,700 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $24,961 | $13,800 | $14,000 |
| Total | $900,093 | $2,029,343 | $1,068,083 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Perspective Therapeutics, Inc. DEF 14A filed April 16, 2026, accession 0001193125-26-159005, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Perspective Therapeutics, Inc. filed document, accession 0001193125-26-159005. Every figure is read from that document and cited to the page and table it appears in. Filed April 16, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 134,063 | — | $2.46 |
| Option | 36,940 | — | $2.40 |
| Option | 93,750 | — | $10.65 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Perspective Therapeutics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Perspective Therapeutics’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Johan Spoor | Chief Executive Officer, Director | $2,404,692 |
| Juan Graham | Former Chief Financial Officer | $2,234,930 |
| Joel Sendek | Chief Financial Officer | $1,986,552 |
| Markus Puhlmann · this page | Chief Medical Officer | $1,068,083 |
Markus Puhlmann's compensation dossier, Perspective Therapeutics
You have read Markus Puhlmann's totals and holdings. The dossier adds each equity grant Perspective Therapeutics disclosed for Markus Puhlmann and Perspective Therapeutics's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full Perspective Therapeutics compensation record
free company briefThis page is one person within Perspective Therapeutics's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Perspective Therapeutics proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Perspective Therapeutics's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Perspective Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order CATX
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.